1. Avinger Offers A Better Mousetrap, But A Lot Of Challenges

    Avinger Offers A Better Mousetrap, But A Lot Of Challenges

    Summary: Adding high-quality imaging to mechanical atherectomy could be a powerful combination that finally ignites a $500 million-plus market that has long frustrated med-tech watchers. Avinger is short on cash and has a lot of spending to do to drive market share into the teens and beyond; dilution seems like a certainty today. An EV/revenue multiple between 4.5x and 5x supports a $7 FV today, and high-growth med-tech stocks can trade well above 5x forward revenue during the good times.

    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned

  3. Authors